Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2014

Conditions
PCOS
Interventions
DRUG

Dexamethasone

Each subject in each group will receive 1 mg of oral dexamethasone in the evening and return in the morning for an injection of 25ug of IV recombinant human chorionic gonadotropin. Subjects will also have blood drawn at times -0.5, 0, 0.5, and 24 hours after the injection of r-hCG for measurement of steroid hormones.

DRUG

recombinant human chorionic gonadotropin (r-hCG)

Each subject in each group will receive 1 mg of oral dexamethasone in the evening and return in the morning for an injection of 25ug of IV recombinant human chorionic gonadotropin (r-hCG). Subjects will also have blood drawn at times -0.5, 0, 0.5, and 24 hours after the injection of r-hCG for measurement of steroid hormones.

Trial Locations (1)

92093

UCSD School of Medicine, La Jolla

All Listed Sponsors
collaborator

University of Virginia

OTHER

lead

University of California, San Diego

OTHER

NCT01154192 - Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS) | Biotech Hunter | Biotech Hunter